[metaslider id="485"]

Annals of Vascular Diseases (AVD) is an international, peer-reviewed, open access journal publishing articles on vascular disease. Published continuously online, the journal is fully indexed in J-STAGE and PubMed Central. AVD welcomes submissions from around the world.

Announcements

The licensing policy for our journal has been updated. Starting from January 1, 2025, newly published articles will generally be licensed under the CC BY (Attribution) license.

– Articles published on or after January 1, 2025: Licensed under CC BY (Attribution).
– Articles published before January 1, 2025: Retain their original license, CC BY-NC-SA (Attribution-NonCommercial-ShareAlike).
– Secondary publications (e.g., translations) may follow the licensing terms of the primary publication.

For more details, please refer to the “Copyright, Open Access and Fees” section of the Instructions to Authors.

About the journal

AVD is an official journal of Asian Society for Vascular Surgery (ASVS) and Asian Venous Forum, sponsored by Japanese College of Angiology, Japanese Society for Vascular Surgery and the Japanese Society of Phlebology.

Read more

Readers

Anyone may access all articles in AVD from J-STAGE and PMC.

Read more

Contact

This site is operated by Editorial Committee of Annals of Vascular Diseases.

Editorial Committee of Annals of Vascular Diseases
c/o Academy Center, Yamabuki-cho 358-5, Shinjuku-ku, Tokyo 162-0801, Japan
TEL: +81-3-6824-9399
E-mail: avd-edit[at]je.bunken.co.jp
(Note : change [at] to @ when typing in address.)

Read more

Latest articles

Case ReportFebruary 17, 2026

Staged Endovascular and Surgical Management of Pediatric Tracheo-Innominate Artery Fistula: A Case Report

Yuchen Cao, Masaaki Koide, Masafumi Yashima, Hisashi Sugiyama, Yasumi Nakashima, Arika Matsushita, Kotaro Ishida, Yusuke Okui

Tracheo-innominate artery fistula (TIF) is rare but potentially fatal, especially in pediatric patients. We present a case treated by emergency endovascular stenting followed by elective open surgery. Stent grafting achieved immediate hemostasis and served as a lifesaving bridge, but its limitations—including risks of infection, rebleeding, and graft mismatch due to somatic growth—made definitive surgery necessary. Laryngoscopic findings revealed intratracheal graft exposure, prompting timely graft removal and tracheal repair. This staged strategy highlights both the value of stenting as bridging therapy and the importance of early multidisciplinary planning in pediatric TIF.

Read full Article

Case ReportFebruary 17, 2026

Successful Treatment for a Huge Pulmonary Pseudoaneurysm in the Interlobar Segment with Coil Embolization: A Case Report

Masao Takahashi, Koichiro Matsuura, Ken Nakazawa, Yoko Usami, Shunsuke Yamada, Satoru Mochida, Cho Konjo, Kaiji Inoue, Eito Kozawa

A 62-year-old male with empyema underwent an attempted pleural drainage, which resulted in iatrogenic pseudoaneurysm formation of the right pulmonary artery in the interlobar segment. Endovascular treatment was favored over surgical intervention due to the presence of empyema. The pulmonary artery in the interlobar segment was embolized with metallic coils, with inevitable occlusion of blood perfusion in the middle and lower lobes. Despite the perfusion loss in a large lung territory, the patient eventually required no supplemental oxygenation. Coil embolization can be a favorable alternative to stent-grafting for pseudoaneurysm even in the interlobar segment, despite the potential risk of post-procedure hypoxemia.

Read full Article

Case ReportFebruary 17, 2026

Treatment of a Type II Endoleak from an Atypical Mediastinal Collateral Branch Following Total Arch Replacement with Frozen Elephant Trunk

Emiko Chiba, Kohei Hamamoto, Mamoru Arakawa, Satoshi Uesugi, Soichiro Kojima, Ryoma Kobayashi, Tatsuya Ogawa, Hiroyuki Fujii, Mitsuru Matsuki, Harushi Mori

We present a rare case of type II endoleak (T2EL) from an atypical mediastinal artery following total arch replacement with a frozen elephant trunk (FET) for chronic aortic dissection. A 63-year-old male with a history of multiple thoracic aortic surgeries, including FET, developed enlargement of an aortic arch aneurysm on follow-up. Computed tomography and diagnostic angiography revealed a T2EL due to a newly developed mediastinal collateral artery arising from the left subclavian artery feeding the sac. Selective transcatheter embolization with N-butyl-2-cyanoacrylate successfully eliminated the endoleak. Recognizing such atypical T2EL sources is crucial for managing post-FET aneurysm expansion.

Read full Article

Original ArticleFebruary 7, 2026

Objectives: We conducted a detailed comparison of inpatient medical costs between endovascular aneurysm repair (EVAR) and open aneurysm repair (OAR) for abdominal aortic aneurysms.
Methods: We evaluated 312 EVAR and 205 OAR cases performed at our institution between January 2007 and December 2017. Patient background characteristics were adjusted between the EVAR and OAR groups using propensity score matching (PSM). Surgical outcomes and inpatient medical costs were compared.
Results: After PSM, 161 cases were included in each group for comparison. Operative time, blood loss, intensive care unit (ICU) stay, and hospital stay were significantly lower in the EVAR group than in the OAR group. Total inpatient medical costs were significantly higher in the EVAR group (3111× 103 vs. 2156 × 103 JPY [Japanese yen], p <0.01). The surgical material costs in the EVAR group were significantly higher than those in the OAR group, accounting for 58% of total medical expenses. Other costs (diagnosis procedure combination, ICU management, surgical procedure, transfusion, intraoperative injection, and room) were all lower in the EVAR group than in the OAR group.
Conclusions: The cost-saving effects of EVAR, such as reduced transfusion costs and ICU stay fees, were offset by the significantly higher cost of surgical materials.

Read full Article

Review ArticleFebruary 7, 2026

Physician-Modified Endografts for Complex Aortic Aneurysms in Japan: Current Status, Clinical Outcomes, and Guideline Integration

Tsuyoshi Shibata, Yutaka Iba, Shingo Tsushima, Tomohiro Nakajima, Junji Nakazawa, Ayaka Arihara, Kenichi Kato, Shigeki Komatsu, Masato Yonemori, Kenta Yoshikawa, Shun Hayasaka, Hirokazu Sugiura, Hajime Maeda, Nobuyoshi Kawaharada

In Japan, the absence of commercially available fenestrated and/or branched endografts has necessitated widespread adoption of physician-modified endografts (PMEGs) for complex aortic aneurysms. This paper compares PMEG use in Western countries and Japan, summarizes multicenter outcome data, and highlights the gap between real-world practice and current Japanese aortic disease guidelines. Recent Japanese series report high technical success and acceptable mid-term outcomes, comparable to Western reports. While long-term durability remains uncertain, structured training, national registries, and standardized protocols are essential. Guideline acknowledgment of PMEGs could improve safety, consistency, and international alignment in complex endovascular therapy. Establishing structured training, national registries, and evidence-based policy recognition of PMEGs is essential to ensure safe and standardized practice in Japan.

Read full Article

Case ReportFebruary 6, 2026

Thoracic Endovascular Aortic Repair with Reverse Aortic Arch Debranching Technique for Ascending Aortic Pseudoaneurysm

Hiroki Tada, Keiwa Kin, Tsubasa Mikami, Kazuma Handa, Junya Yokoyama, Yukitoshi Shirakawa

Ascending aortic pseudoaneurysm is a rare but life-threatening complication after cardiac surgery, typically requiring redo open repair with substantial risk. We report a 58-year-old male with an incidental 85-mm ascending pseudoaneurysm discovered during evaluation for recurrent hepatocellular carcinoma. Due to prior sternotomy, cirrhosis, and urgent oncologic need, open surgery was deemed prohibitive. He successfully underwent thoracic endovascular repair with reverse extra-anatomical aortic arch debranching technique. He recovered uneventfully and proceeded to cancer treatment without delay. This case highlights the feasibility of hybrid endovascular strategies for ascending aortic pathology in high-risk patients.

Read full Article